BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 28, 2018
View Archived Issues
Revolution Medicines advances potent, orally available SHP-2 allosteric inhibitor
Read More
Phase I results presented for rebamipide prodrug SA-001
Read More
Sujanu combination tablets approved in Japan
Read More
New biomarkers and targets for cutaneous T-cell lymphomas found via N-glycoproteomic analysis
Read More
Novartis divesting stake in healthcare joint venture to GSK
Read More
Polyphor initiates phase III trial of murepavadin for nosocomial pneumonia
Read More
FDA grants priority review to sBLA for Opdivo plus Yervoy for MSI-H or dMMR colorectal cancer
Read More
Novel small molecules inhibit Escherichia coli FmlH to treat urinary tract infections
Read More
Servier initiates phase I study of MRG-110
Read More
Tyme initiates phase II trial of SM-88 in metastatic pancreatic cancer
Read More
Japanese Sakigake designation granted to AveXis' AVXS-101 for SMA type 1
Read More
Japan's MHLW grants Sakigake designation to JR-141 for Hunter's syndrome
Read More
European Commission expands indication for Feraccru
Read More
FDA grants breakthrough therapy designation to Pedmark
Read More
Krystal files IND with FDA for phase I/II study of KB-103 for dystrophic EB
Read More
Sirenas describes novel cyclic peptide analogues
Read More
Novel metabotropic glutamate mGlu7 receptor agonists synthesized at Takeda
Read More
Sichuan Kelun-Biotech Biopharmaceutical patents thrombopoietin receptor agonists
Read More
Shanghai Institute Materia Medica, Shanghai Haihe Pharmaceutical divulge new EZH2 inhibitors
Read More
Aurigene Discovery Technologies presents novel VISTA protein inhibitors
Read More
Japanese Sakigake designation granted to cancer programs
Read More
KIFC1 a potentially new and druggable target for colorectal carcinoma
Read More
Altimmune updates NasoVAX and HepTcell programs
Read More
Bardoxolone methyl granted Sakigake designation in Japan
Read More
AnaptysBio reports encouraging topline proof-of-concept data for ANB-020 in peanut allergy
Read More
Carna Biosciences enters joint research agreement with Sumitomo Dainippon Pharma
Read More
FDA advisory committee recommends approval of Lucemyra
Read More
Semglee biosimilar insulin glargine approved in E.U. and Australia
Read More
EMA validates application for Cabometyx for previously treated advanced HCC
Read More